Main menu
Edison Group
  • Home
  • Sparks
  • Equities

    Equities

    View All Equities

    Equities by Sector

    The Schiehallion Fund

    MCap

    USD2,257m

    Last close

    USD2.20

    ▲ 157.80 (7,172.73%)

    Percheron Therapeutics

    MCap

    AUD10m

    Last close

    AUD0.01

    ▲ 0.00 (20.00%)

    Metals One

    MCap

    —

    Last close

    GBP0.01

    ▲ 0.18 (19.44%)

  • Sectors

    Sectors

    View All Sectors
  • Megatrends

    Megatrends

  • Thematics

    Thematics

    View All Thematics

    Latest

  • Audiovisual

    Audiovisual

    View All Audiovisual

    Latest

Sparks commentary - Newron Pharmaceuticals

Healthcare

Sparks - Newron Pharmaceuticals

More on this equity
Newron Pharmaceuticals (SIX: NWRN) improves funding visibility ahead of pivotal readout
Published by Arron Aatkar, PhD

Newron Pharmaceuticals has secured the second tranche, comprising €5.5m, of its €38m equity financing (first announced in February 2026), through the issuance of 433,070 new shares, taking gross proceeds subscribed to date by the investor group to c €20.5m. A further €5.5m tranche is expected by 30 November 2026, while the remaining €12m is conditional on positive ENIGMA-TRS results; overall, the financing is expected to fund the global Phase III programme and extend Newron’s cash runway beyond the pivotal 12-week readout. With screening for ENIGMA-TRS 1 now complete and 12-week results expected in Q127, we view the latest subscription as further reducing near-term financing risk ahead of this key clinical catalyst.

Next Sparks Commentary in this sector >

Latest

Industrials | Comment

Jersey Electricity (LSE: JEL) – Refinancing increases funding flexibility for £180m investment programme

TMT | Comment

Molten Ventures (LSE: GROW): Isar Aerospace successfully delivered satellites into orbit

TMT | Comment

Team Internet: H1 confirms improving operating momentum

Industrials | Comment

SigmaRoc (AIM: SRC) – strong H1 performance complemented by Dolomitas acquisition

Industrials | Comment

Alkemya Metacore secures initial $50m investment ahead of listing
Cookie Policy Overview
Edison Group

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping us understand which section of the website you find more interesting and useful. See our Cookie Policy for more information.

Strictly necessary and functional

These cookies are used to deliver our website and content. Strictly necessary cookies relate to our hosting environment, and functional cookies are used to facilitate social logins, social sharing and rich-media content embeds.

Advertising

Advertising Cookies collect information about your browsing habits such as the pages you visit and links you follow. These audience insights are used to make our website more relevant.

Performance

Performance Cookies collect anonymous information designed to help us improve the site and respond to the needs of our audiences. We use this information to make our site faster, more relevant and improve the navigation for all users.